Recent Updates
Recently added Catalysts
ATHE Neutral Sentiment Score: 50/100

ASX ANNOUNCEMENT 04 February 2025 Notice Under Section 708A(5)(e) of the Corporations Act This notice is given by Alterity Therapeutics Limited ACN 080 699 065 (ASX: ATH, NASDAQ: ATHE) ("Alterity" or "the Company"), unde

Key Takeaway: Alterity Therapeutics Limited has issued a notice under Section 708A(5)(e) of the Corporations Act regarding the issuance of fully paid ordinary shares. On February 3, 2025, the company issued 164,242,200 shares as part of a previously announced transaction. The notice is a formal declaration to comply with Australian securities regulations, indicating that these securities will be quoted on the ASX. The company has provided details about the issued capital and future potential securities.

Market Sentiment Analysis

Full Press Release Details

Notice Under Section 708A(5)(e) of the Corporations
This notice is given by Alterity Therapeutics
Limited ACN 080 699 065 (ASX: ATH, NASDAQ: ATHE) ("Alterity" or "the Company"), under section 708A(5)(e) of the
Corporations Act 2001 (Cth) (Corporations Act).
Details of securities issued
Type: Shares
Class/Description: Fully paid ordinary shares
ASX Code: ATH
Date of Issue: 03 February 2025
Number Issued: 164,242,200
The Company gives notice pursuant to section 708A(5)(e)
of the Corporations Act that:
/s/ Abby Macnish Niven
Abby Macnish Niven
Company Secretary
Alterity Therapeutics Limited ACN 080 699 065
Level 14, 350 Collins Street, Melbourne, Victoria 3000 Australia
ALTERITY THERAPEUTICS LIMITED
Date of this announcement
Tuesday February 04, 2025
+securities to be quoted are:
+Securities issued as part of a transaction or transactions previously announced to the market in an Appendix 3B
Total number of +securities to be quoted
ASX + security code Security description Number of +securities to be quoted Issue date
ATH ORDINARY FULLY PAID 164,242,200 03/02/2025
Refer to next page for full details of the announcement
Part 1 - Entity and announcement details
ALTERITY THERAPEUTICS LIMITED
We (the entity named above) apply for +quotation of
the following +securities and agree to the matters set out in Appendix 2A of the ASX Listing Rules.
1.2 Registered number type Registration number
ABN 37080699065
Date of this announcement
Part 2 - Type of Issue
+securities to be quoted are:
+Securities issued as part of a transaction or transactions previously announced to the market in an Appendix 3B
Previous Appendix 3B details:
Announcement Date and Time Announcement Title Selected Appendix 3B to submit quotation request
03-Feb-2025 09:58 New - Proposed issue of securities - ATH A placement or other type of issue
2.3a.2 Are there any further issues of +securities yet to take place to complete the transaction(s) referred to in the Appendix 3B?
Part 3A - number and type of +securities to be quoted where issue has previously been notified to ASX in an Appendix 3B
ASX +security code and description
Distribution Schedule
Provide a distribution schedule for the new +securities
according to the categories set out in the left hand column - including the number of recipients and the total percentage of the new
+securities held by the recipients in each category.
Total percentage of +securities held
Number of +securities held Number of holders For example, to enter a value of 50% please input as 50.00
1 - 1,000 %
1,001 - 5,000 %
5,001 - 10,000 %
10,001 - 100,000 %
100,001 and over %
Number of +securities to be quoted
Are the +securities being issued for a cash consideration?
In what currency is the cash consideration being paid? What is the issue price per +security?
AUD - Australian Dollar AUD 0.01290000
information the entity wishes to provide about the +securities to be quoted
Part 4 - Issued capital following quotation
quotation of the +securities the subject of this application, the issued capital of the entity will comprise:
The figures in parts 4.1 and 4.2 below are automatically generated and may not reflect the entity's current issued capital if other Appendix
2A, Appendix 3G or Appendix 3H forms are currently with ASX for processing.
+securities (total number of each +class of +securities quoted on ASX following the +quotation of the +securities subject of this
ASX +security code and description Total number of +securities on issue
ATH : ORDINARY FULLY PAID 5,491,006,889
ATHO : OPTION EXPIRING 31-AUG-2026 932,611,430
+securities (Total number of each +class of +securities issued but not quoted on ASX)
ASX +security code and description Total number of +securities on issue
ATHAAE : OPTION EXPIRING 29-NOV-2026 EX $0.0375 14,250,000
ATHAAG : OPTION EXPIRING 29-NOV-2026 EX $0.0238 11,900,000
ATHAAB : OPTION EXPIRING 17-SEP-2025 EX $0.09 35,000,000
ATHAAK : OPTION EXPIRING 30-DEC-2027 EX $0.01 170,000,000
ATHAAH : OPTION EXPIRING 19-DEC-2026 EX $0.0105 8,000,000
ATHAB : OPTION EXPIRING 13-MAR-2029 EX US$0.0031 62,500,000
ATHAA : OPTION EXPIRING 13-MAR-2029 EX $0.004 20,166,667
ATHAC : OPTION EXPIRING 21-MAR-2029 EX US$0.003 120,000,000
ATHAAD : OPTION EXPIRING 06-JAN-2026 EX $0.032 91,392,720

Frequently Asked Questions

What type of shares did Alterity Therapeutics issue?

Alterity Therapeutics issued fully paid ordinary shares.

How many shares were issued by Alterity on February 3, 2025?

Alterity issued a total of 164,242,200 shares on February 3, 2025.

What is the ASX code for Alterity Therapeutics?

The ASX code for Alterity Therapeutics is ATH.

What was the issue price per share?

The issue price per share was AUD 0.0129.

Who is the Company Secretary for Alterity Therapeutics?

Abby Macnish Niven is the Company Secretary for Alterity Therapeutics.

Last updated: Feb 4, 2025